Related Experiment Video
Updated: Feb 26, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
895
Bronchial artery embolization in hemoptysis: a systematic review
Ananya Panda1, Ashu Seith Bhalla, Ankur Goyal
1Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India. ashubhalla1@yahoo.com.
Diagnostic and Interventional Radiology (Ankara, Turkey)
|July 14, 2017
Summary
Bronchial artery embolization (BAE) is a key minimally invasive treatment for hemoptysis, achieving high immediate success rates. However, recurrence is common, particularly with specific conditions, necessitating careful patient selection and management.
Area of Science:
- Interventional Radiology
- Pulmonary Medicine
- Vascular Surgery
Background:
- Hemoptysis, or coughing up blood, poses significant clinical challenges.
- Bronchial artery embolization (BAE) is an established interventional procedure for managing hemoptysis.
Purpose of the Study:
- To systematically review the efficacy and outcomes of bronchial artery embolization (BAE) for treating hemoptysis.
- To identify factors influencing BAE success and recurrence rates.
Main Methods:
- A systematic literature review of 22 studies published between 1976 and 2016.
- Inclusion criteria required a minimum sample size of 50 patients and reporting on indications, technique, efficacy, and follow-up.
Main Results:
- Common indications for BAE include tuberculosis, bronchiectasis, and aspergillomas.
- Immediate clinical success rates ranged from 70%-99%, but recurrence rates were high (10%-57%).
- Factors like aspergillomas, active TB, and collateral vessel formation were linked to higher recurrence.
Conclusions:
- BAE is a first-line, minimally invasive treatment for hemoptysis, especially in emergencies or high-risk patients.
- Despite recurrence challenges, BAE offers a valuable therapeutic option with low major complication rates.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
553
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
553
01:29Pulmonary Embolism I: Introduction
997
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
997
01:27Pulmonary Embolism III: Nursing Management
539
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
539
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
508
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
508
01:26COPD: Management Using Bronchodilators and Corticosteroids
950
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
950